Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter bids general counsel adieu

This article was originally published in The Gray Sheet

Executive Summary

Marla Persky, 48, assumes acting general counsel title in wake of Thomas Sabatino's decision to resign from firm and become Schering-Plough's general counsel, effective April 15. A 16-year Baxter veteran, Persky had been serving as deputy general counsel and managing the law function for the company's renal business, as well as its litigation, regulatory and intercontinental legal teams. Baxter is seeking a permanent replacement for Sabatino, who recently helped craft AdvaMed's code of ethics. The firm continues to work with headhunter Heidrick & Struggles to fill the CEO spot to be vacated by Harry Kraemer (1"The Gray Sheet" Feb. 4, 2004, p. 11)...
Advertisement

Related Content

Buck Stops With Kraemer: Baxter CEO Resigns To Restore Investor Confidence
Buck Stops With Kraemer: Baxter CEO Resigns To Restore Investor Confidence
Advertisement
UsernamePublicRestriction

Register

MT019927

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel